Literature DB >> 16449340

Contributions of different fatty acid sources to very low-density lipoprotein-triacylglycerol in the fasted and fed states.

Brian R Barrows1, Elizabeth J Parks.   

Abstract

CONTEXT: The liver's regulation of fatty acids (FAs) postprandially may contribute to risk of metabolic diseases.
OBJECTIVE: Measurements of steady-state metabolism were used to investigate sources of FAs used for very low-density lipoprotein (VLDL)-triacylglycerol (TG) synthesis during fasting and feeding in vivo. DESIGN/INTERVENTION: Subjects were duodenally fed a formula labeled with the stable isotope glyceryl tri-palmitate-d(31) and iv infused with [1,2,3,4-(13)C(4)]-palmitatic acid and [1-(13)C(1)]-acetate to quantitate the liver's use of FAs originating from adipose tissue and de novo lipogenesis. SETTING/PARTICIPANTS: This study of healthy men (n = 12; body mass index, 24.4 +/- 2.7 kg/m(2)) was conducted at a General Clinical Research Center. MAIN OUTCOME MEASURES: Concentrations of metabolites during fasting and feeding, sources of FAs used for lipoprotein synthesis, rate of appearance of serum nonesterified FA (NEFA), and VLDL-TG were measured.
RESULTS: During fasting, 77.2 +/- 14.0% of VLDL-TG was derived from adipose FA recycling and 4.0 +/- 3.6% from lipogenesis; with feeding, 43.6 +/- 18.6% came from adipose FAs (P < 0.001), 8.2 +/- 5.1% from lipogenesis (P < 0.001), 15.2 +/- 13.7% from uptake of chylomicron-remnant TG, and 10.3 +/- 6.9% from dietary FA spillover into the serum NEFA pool. Fed-state VLDL-TG from NEFA reesterification decreased in proportion to the reduction in adipose NEFA appearance.
CONCLUSION: These data: 1) quantify the extent to which the healthy liver manages its use of different sources of FAs that flow to it, 2) demonstrate how the postprandial reduction in adipose-NEFA flux may be partially replaced by other sources, and 3) highlight the potential for dietary FA spillover to support the continued dominance of NEFA as a substrate for VLDL-TG synthesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16449340     DOI: 10.1210/jc.2005-1709

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  80 in total

1.  Activation of the farnesoid X receptor induces hepatic expression and secretion of fibroblast growth factor 21.

Authors:  Holly A Cyphert; Xuemei Ge; Alison B Kohan; Lisa M Salati; Yanqiao Zhang; F Bradley Hillgartner
Journal:  J Biol Chem       Date:  2012-06-01       Impact factor: 5.157

2.  Insulin activation of plasma nonesterified fatty acid uptake in metabolic syndrome.

Authors:  Maria A Ramos-Roman; Smadar A Lapidot; Robert D Phair; Elizabeth J Parks
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-06-21       Impact factor: 8.311

Review 3.  Postprandial metabolism of meal triglyceride in humans.

Authors:  Jennifer E Lambert; Elizabeth J Parks
Journal:  Biochim Biophys Acta       Date:  2012-01-17

4.  Hepatic De Novo Lipogenesis in Obese Youth Is Modulated by a Common Variant in the GCKR Gene.

Authors:  Nicola Santoro; Sonia Caprio; Bridget Pierpont; Michelle Van Name; Mary Savoye; Elizabeth J Parks
Journal:  J Clin Endocrinol Metab       Date:  2015-06-04       Impact factor: 5.958

5.  Insulin-independent regulation of hepatic triglyceride synthesis by fatty acids.

Authors:  Daniel F Vatner; Sachin K Majumdar; Naoki Kumashiro; Max C Petersen; Yasmeen Rahimi; Arijeet K Gattu; Mitchell Bears; João-Paulo G Camporez; Gary W Cline; Michael J Jurczak; Varman T Samuel; Gerald I Shulman
Journal:  Proc Natl Acad Sci U S A       Date:  2015-01-06       Impact factor: 11.205

6.  GPR146 Deficiency Protects against Hypercholesterolemia and Atherosclerosis.

Authors:  Haojie Yu; Antoine Rimbert; Alice E Palmer; Takafumi Toyohara; Yulei Xia; Fang Xia; Leonardo M R Ferreira; Zhifen Chen; Tao Chen; Natalia Loaiza; Nathaniel Brooks Horwitz; Michael C Kacergis; Liping Zhao; Alexander A Soukas; Jan Albert Kuivenhoven; Sekar Kathiresan; Chad A Cowan
Journal:  Cell       Date:  2019-11-27       Impact factor: 41.582

7.  Association of NEFA composition with insulin sensitivity and beta cell function in the Prospective Metabolism and Islet Cell Evaluation (PROMISE) cohort.

Authors:  Luke W Johnston; Stewart B Harris; Ravi Retnakaran; Adria Giacca; Zhen Liu; Richard P Bazinet; Anthony J Hanley
Journal:  Diabetologia       Date:  2017-12-24       Impact factor: 10.122

8.  Greater dietary fat oxidation in obese compared with lean men: an adaptive mechanism to prevent liver fat accumulation?

Authors:  Leanne Hodson; Siobhán E McQuaid; Sandy M Humphreys; Ross Milne; Barbara A Fielding; Keith N Frayn; Fredrik Karpe
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-07-13       Impact factor: 4.310

9.  Central nervous system neuropeptide Y signaling via the Y1 receptor partially dissociates feeding behavior from lipoprotein metabolism in lean rats.

Authors:  Jennifer M Rojas; John M Stafford; Sanaz Saadat; Richard L Printz; Annette G Beck-Sickinger; Kevin D Niswender
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-10-16       Impact factor: 4.310

10.  Relationship between body fat mass and free fatty acid kinetics in men and women.

Authors:  Bettina Mittendorfer; Faidon Magkos; Elisa Fabbrini; B Selma Mohammed; Samuel Klein
Journal:  Obesity (Silver Spring)       Date:  2009-07-23       Impact factor: 5.002

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.